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Abstract 
Epstein-Barr virus infectious mononucleosis can cause transient immune deficiency 
which may predispose to reactivation of latent herpes simplex virus (HSV) infection in 
the immunocompetent host. We report the case of a 15-year-old male who presented 
with severe odynophagia and herpes labialis during the course of Epstein-Barr virus 
infectious mononucleosis that had been diagnosed ten days before. Esophagoscopy 
revealed extensive ulcerations with distinct borders and whitish exudates at the mid and 
distal esophagus. Polymerase chain reaction detected HSV-1 DNA in the biopsy 
specimens. The patient was treated with intravenous acyclovir. The symptoms resolved 
rapidly within 3 days, in accordance with improved endoscopic findings. 
 
Introduction 
Epstein-Barr virus infectious mononucleosis (EBV-IM) is a common infection that 
affects 25 to 30% of adolescents and adults up to 30 years of age [1]. EBV-IM can be 
complicated by streptococcal pharyngitis in 10% of cases but has not been identified as a 
predisposing factor for secondary viral infections [2]. Herpes simplex virus (HSV) is a 
rare cause of esophagitis in the immunocompetent host. We present the case of a 
15-year-old male who was admitted with HSV-1 eosophagitis (HSVE) ten days after the 
diagnosis of EBV-IM.  
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Case Report 
 A 15-year-old male presented with a 2-day history of severe odynophagia and malaise. Ten days 
before admission, the patient had visited his general practitioner because of a sore throat and fever and 
been diagnosed with EBV-IM. He reported no medical history of recurrent infections and he was not 
receiving any medication. At admission, his temperature was normal. Physical examination revealed 
small palpable cervical lymph nodes and a brownish exophytic lesion on his lower lip, compatible with 
severe manifestation of herpes labialis. Despite the severity of the lip lesion, examination of the oral 
cavity and throat did not reveal any abnormal findings. Erythrocyte sedimentation rate was 50 mm/h 
while the rest of the routine laboratory tests were normal, including blood and differential count. 
Immunoglobulin quantitation was normal, while T cell and B cell count were not performed. 
Esophagoscopy revealed confluent linear and roundish ulcerations in the mid and distal esophagus, 
which had distinct borders and were covered by whitish exudates. The mucosa among the ulcerations 
was friable and hemorrhagic (fig. 1). Multiple biopsies were obtained from the edge of the ulcers. 
Histopathology showed acute severe inflammation of the squamous epithelium with no viral inclusion 
bodies. The diagnosis was made by detecting HSV-1 DNA with polymerase chain reaction (PCR) in the 
biopsy specimens. Serology revealed elevated IgM and IgG antibodies against the viral capsid antibody 
of the EBV which confirmed recent infection with the virus. The IgM antibody (ELISA) against HSV-1 
was negative while the IgG was positive. Human immunodeficiency virus serology was negative.  
Due to the severity of the odynophagia and the endoscopic appearance, acyclovir was administered 
intravenously (5 mg/kg three times daily) and clinical improvement was rapidly observed. Three days 
after acyclovir administration, second-look esophagoscopy showed a marked improvement of the 
esophageal lesions; the depth and the width of the lesions were significantly reduced, and normal 
mucosa could be seen among the ulcerations (fig. 2). The patient had an uneventful recovery and one 
year later he was in good health. His laboratory tests were within normal limits. 
Discussion 
To our knowledge this is the first case of EBV-IM in a previously healthy individual 
complicated by HSVE. Although the underlying mechanism for this complication is 
unclear, we hypothesize that immune deficiency during acute EBV infection might lead to 
reactivation of HSV [3]. In acute EBV infection the infected B cells produce antibodies 
against the host cells and virus proteins. CD8+ cytotoxic T cells are responsible for 
suppressing the replication of the virus. The population of the CD8+ cytotoxic T cells 
expands, inverting the CD4+/CD8+ ratio, and almost half of them are directed against the 
virus [4]. Junker et al. [5] showed that EBV affects both B and T lymphocytes and causes 
broad-based transient immune deficiency in patients with uncomplicated infection. The 
impaired B cells produce deficient quantities of antibodies while T suppressor cells inhibit 
antibody production [5, 6]. HSV proliferation causes infections that are also controlled by 
CD8+ T cells. 
Affinity of HSV to squamous epithelia predisposes the esophagus to be affected [7]. 
HSVE in an immunocompetent host can present either as a primary or recurrent 
infection. Gingivostomatitis with bilateral oropharyngeal lesions, ulcerations and 
erythema of the gingiva, buccal mucosa and tongue, lymphadenopathy and fever are usual 
manifestations of primary infection, while unilateral oropharyngeal lesions and cold sores 
suggest secondary infection [8].The HSV infection in our case is considered recurrent 
because of the IgG seropositivity at admission and the cold sores (herpes labialis). Herpes 
labialis appears in 20 to 40% of seropositive individuals and has been reported to present 
with HSVE in another two cases [8–10]. It seems that HSV primary infection in young 
healthy adults causes more severe symptoms compared to HSV infection in childhood. 
Improved hygiene is one of the reasons for the delayed contact with the virus. 
HSV causes similar endoscopic findings in the esophagus of both immunocompetent 
and immunocompromised patients. Located usually in the mid-distal esophagus, the  
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usual appearance of HSVE is of friable, hemorrhagic mucosa with ulcerations of various 
depth and length that coalesce. Biopsies from the edge of the ulcers are the appropriate 
specimen for detecting the virus. Inclusion viral bodies cannot be found in half of the 
cases [11] and PCR has lately been used for detecting virus DNA in the biopsy specimens. 
PCR is a more sensitive, cost-effective and rapid method compared to the viral cultures 
and enzyme immunoassay, providing results within a few hours [12, 13]. Serology has 
restricted diagnostic value since 90% of healthy teenagers are seropositive. Only 
seroconversion from negative to positive HSV antibody can provide information of recent 
infection. Only 5% of the seropositive patients who undergo reactivation of the virus have 
a four-fold rise in titre of the antibody to HSV [14]. Although infection in the 
immunocompetent host is self-limited, in the presence of immunodeficiency, marked 
clinical symptoms, or complicated course treatment with the guanosine analogue 
acyclovir shortens the duration of the symptoms and esophageal lesions. Improvement of 
odynophagia is expected within 24–72 h and early onset of therapy is believed to speed up 
symptom resolution [15]. However, whether improvement of the symptoms is the result 
of acyclovir or of the natural course of the disease is an issue of debate, due to the low 
incidence of HSVE in immunocompetent patients. 
In conclusion, we report a young patient who presented with HSVE ten days after the 
diagnosis of EBV-IM. The transient immune deficiency caused by EBV-IM is believed to 
be the predisposing factor for the reactivation of HSV. In view of the rarity of this 
condition and the low sensitivity of macroscopic assessment, a high index of suspicion is 
certainly necessary. 
 
 
 
 
 
Fig. 1. Endoscopic image at admission: confluent linear and roundish ulcerations in the esophagus 
with distinct borders and coverage of whitish exudates. 
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Fig. 2. Endoscopic image 3 days after acyclovir administration: depth and width of the lesions are 
significantly reduced and normal mucosa appears among the ulcerations. 
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